The circulating CD4+CXCR5+FOXP3+ Tfrs with enhanced suppressive function could alleviate autoimmunity in RA patients by reducing IgG and IgM levels, and the proportion of Tfrs was negatively correlated with the disease severity, which provided a novel insight into RA pathogenesis. Here, CXCR5 is linked to rheumatoid arthritis.